Axol Bioscience

Axol Bioscience's Product Range

Axol Bioscience offers an extensive range of human induced pluripotent stem cell (iPSC)-derived cells, including neurons, cardiomyocytes, and sensory neurons. These products cater to various research and development needs, particularly in the fields of disease modeling and drug discovery. The company's iPSC-derived cells are essential for studying neurological and cardiovascular diseases, providing researchers with reliable and physiologically relevant cellular models.

Axol Bioscience's Custom Lab Services

Axol Bioscience provides a suite of bespoke lab services, which include reprogramming, gene editing, and cellular assays. These custom services are designed to meet the specific requirements of researchers and pharmaceutical companies. By offering tailored solutions, Axol Bioscience helps accelerate scientific discoveries and the development of novel therapeutics. The company's expertise in gene editing and cellular assays is particularly valuable for precision medicine and targeted drug development.

Axol Bioscience's iPSC Library

Axol Bioscience maintains a commercial library of 70 iPSC lines sourced from both patient and healthy donors. This diverse collection includes lines for major conditions such as Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis (ALS). The availability of these iPSC lines supports high-quality research and development efforts in understanding disease mechanisms and testing potential treatments. Researchers benefit from access to well-characterized cellular models that closely mimic human disease pathology.

Axol Bioscience's Disease Modeling and Drug Discovery

Specializing in disease modeling and drug discovery, Axol Bioscience leverages human iPSC technology to create physiologically relevant models for various diseases. These models are crucial for studying disease progression and evaluating the efficacy and safety of new drug candidates. The company's iPSC-derived models are particularly useful for neurotoxicity, sensorytoxicity, and cardiotoxicity testing, providing critical insights into potential side effects and therapeutic windows.

Axol Bioscience's ISO 9001:2015 Accreditation

Axol Bioscience operates an ISO 9001:2015 accredited production facility, ensuring the highest standards of quality management. This accreditation reflects the company's commitment to maintaining rigorous quality control processes and delivering reliable, high-quality products and services. For clients, the ISO 9001:2015 certification provides assurance that Axol Bioscience adheres to international standards, fostering trust and confidence in their offerings.